NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054128

Registered date:12/04/2024

Ensitrelvir Fumaric Acid in Health care workers with SARS-CoV-2 Retrospective Chart Review - Tokyo Rinkai Hospital -

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedCOVID-19
Date of first enrollment2024/04/12
Target sample size100
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeAverage number of days from onset of symptoms to return to work.
Secondary OutcomeVirus residual rate proportion (antigen quantitative test >100 pg / ml) on the planned date of return to work for the re-examination.

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaHealthcare workers at Tokyo Rinkai Hospital who meet any of the following criteria will be excluded from the study. 1)Healthcare workers who were not treated according to the package insert 2)Healthcare workers who received anti-SARS-CoV-2 drugs other than ensitrevir 3)Healthcare workers who refused to participate in this study

Related Information

Contact

public contact
Name Yasuko Ariwa
Address 1-8, Dosho-machi 3-chome, Chuo-ku, Osaka 541-0045, Japan Japan 541-0045
Telephone 06-6202-2161
E-mail yasuko.ariwa@shionogi.co.jp
Affiliation SHIONOGI & Co., Ltd. Medical Affair
scientific contact
Name Makoto Katsuta
Address 1-4-2 Rinkaicho, Edogawa-ku, Tokyo-to Japan
Telephone 03-5605-8811
E-mail katsuta-m@tokyorinkai.jp
Affiliation Tokyo Rinkai Hospital Pharmacy